This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through March 4, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Stride's (LRN) MedCerts & UVI CELL Enter Into a Collaboration
by Zacks Equity Research
Stride's (LRN) subsidiary company, MedCerts, and the University of the Virgin Islands CELL collaborate to offer a variety of programs to students wishing to pursue a career in healthcare.
Lazydays (LAZY) Acquires Orangewood RV Center in Arizona
by Zacks Equity Research
Lazydays (LAZY) expands to its 24th location by acquiring Orangewood RV Center, an dealership in Surprise, AZ.
Zacks.com featured highlights include Stride, EMCOR Group, NetEase and NVIDIA
by Zacks Equity Research
Stride, EMCOR Group, NetEase and NVIDIA are part of the Zacks Screen of the Week article.
4 Must-Buy Momentum Stocks Using the Driehaus Strategy
by Tirthankar Chakraborty
Stocks like Stride (LRN), EMCOR Group (EME), NetEase (NTES), and NVIDIA (NVDA) have been selected as the momentum picks for the day using the Driehaus strategy.
Why K12 (LRN) Might be Well Poised for a Surge
by Zacks Equity Research
K12 (LRN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
K12 (LRN) Is Up 0.23% in One Week: What You Should Know
by Zacks Equity Research
Does K12 (LRN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are Consumer Discretionary Stocks Lagging Stride (LRN) This Year?
by Zacks Equity Research
Here is how K12 (LRN) and Royal Caribbean (RCL) have performed compared to their sector so far this year.
Buy These 4 Low-Beta Stocks to Counter Market Volatility
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Huron (HURN), Stride (LRN), eGain (EGAN) and Southwest Gas Holdings (SWX) are well-poised to gain.
Stride (LRN) Introduces New Long-Term Targets, Stock Up
by Zacks Equity Research
Stride's (LRN) long-term targets demonstrate sustained growth and leverage in the underlying business.
Zacks.com featured highlights include GIII Apparel Group, Stride and Cboe Global
by Zacks Equity Research
GIII Apparel Group, Stride and Cboe Global are part of the Zacks Screen of the Week article.
3 Stocks Trading Near 52-Week High With More Upside Potential
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run lately. Stocks like GIII, LRN and CBOE are seeing price strength and have a high chance of carrying the momentum forward.
3 Top-Ranked Stocks Breaking 52-Week Highs
by Derek Lewis
Stocks nearing or breaking 52-week highs reflect considerable momentum, with positive earnings estimates from analysts commonly providing the fuel needed to continue climbing.
Learn How to Find Top-Ranked Momentum Stocks to Buy in November
by Benjamin Rains
The screen we explore today helps investors find Zacks Rank #1 (Strong Buy) stocks that also boast strong upward price momentum that might be worth buying in November and beyond.
Is American Woodmark (AMWD) Outperforming Other Consumer Discretionary Stocks This Year?
by Zacks Equity Research
Here is how American Woodmark (AMWD) and K12 (LRN) have performed compared to their sector so far this year.
5 Stocks Worth a Buy for Remarkable Earnings Growth
by Tirthankar Chakraborty
Invest in stocks such as Hilton Worldwide (HLT), Stride (LRN), Costco Wholesale (COST), Medpace (MEDP) and H&E Equipment Services (HEES) for superb earnings growth.
Zacks.com featured highlights include Devon Energy, Marathon Oil, Everest Group, Stride and American Woodmark
by Zacks Equity Research
Devon Energy, Marathon Oil, Everest Group, Stride and American Woodmark are part of the Zacks Screen of the Week article.
Buy These 4 Low-Beta Stocks to Counter Market Volatility
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Granite Ridge (GRNT), Ardmore Shipping (ASC), McKesson (MCK) and Stride (LRN) are well-poised to gain.
Is K12 (LRN) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
K12 (LRN) possesses solid growth attributes, which could help it handily outperform the market.
LRN vs. LOPE: Which Stock Is the Better Value Option?
by Zacks Equity Research
LRN vs. LOPE: Which Stock Is the Better Value Option?
Stride, Inc. (LRN) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
K12 (LRN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
5 Attractive PEG-Based GARP Stocks for Investors
by Urmimala Biswas
Here are five PEG-based GARP stocks that qualify our screening criteria - DVN, MRO, EG, LRN and AMWD.
3 Stocks Trading Near 52-Week High That Can Climb Further
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run lately. Stocks like GES, CEG and LRN that are seeing price strength have a high chance of carrying the momentum forward.
K12 (LRN) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
K12 (LRN) delivered earnings and revenue surprises of 128.21% and 5.25%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights Stride, Deckers Outdoor, Molina Healthcare and McKesson
by Zacks Equity Research
Stride, Deckers Outdoor, Molina Healthcare and McKesson have been highlighted in this Screen of The Week article.
K12 (LRN) Upgraded to Buy: Here's Why
by Zacks Equity Research
K12 (LRN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.